Abstract:LI-F type peptides (AMP-jsa9) produced by Paenibacillus polymyxa JSa-9 are a group of cyclic lipodepsipeptide antibiotics that exhibit a broad antimicrobial spectrum against Gram-positive bacteria and filamentous fungi, especially Bacillus cereus and Fusarium moniliforme. In this study, to better understand the antibacterial mechanism of AMP-jsa9 against B. cereus, the ultrastructure of AMP-jsa9-treated B. cereus cells was observed by both atomic force microscopy and transmission electron microscopy, and quantitative proteomic analysis was performed on proteins extracted from treated and untreated bacterial cells by using isobaric tag for relative and absolute quantitation (iTRAQ) labeling and LC-MS/MS analysis to access differentially expressed proteins. Furthermore, multiple experiments were conducted to validate the results of the proteomic analysis, including determinations of ATP, NAD(+)H, NADP(+)H, reactive oxygen species (ROS), the activities of catalase (CAT) and superoxide dismutase (SOD), and the relative expression of target genes by quantitative real-time PCR. Bacterial cells exposed to AMP-jsa9 showed irregular surfaces with bleb projections and concaves; we hypothesize that AMP-jsa9 penetrated the cell wall and was anchored on the cytoplasmic membrane and that ROS accumulated in the cell membrane after treatment with AMP-jsa9, modulating the bacterial membrane properties and increasing membrane permeability. Consequently, the blebs were formed on the cell wall by the impulsive force of the leakage of intercellular contents. iTRAQ-based proteomic analysis detected a total of 1317 proteins, including 176 differentially expressed proteins (75 upregulated (fold >2) and 101 downregulated (fold <0.5)). Based on proteome analysis, the putative pathways of AMP-jsa9 action against B. cereus can be summarized as: (i) inhibition of bacterial sporulation, thiamine biosynthesis, energy metabolism, DNA transcription and translation, and cell wall biosynthesis, through direct regulation of protein levels; and (ii) indirect effects on the same pathways through the accumulation of ROS and the consequent impairment of cellular functions, resulting from downregulation of antioxidant proteins, especially CAT and SOD. Biological significance: The mode of action of LI-F type antimicrobial peptides (AMP-jsa9) against B. cereus was elucidated at the proteomic level. Two pathways of AMP-jsa9 action upon B. cereus cells were identified and the mechanism of bleb formation on the surfaces of bacterial cells was predicted based on the results of ultrastructural observation and proteomic analysis. These results are helpful in understanding the mechanism of LI-F type peptides and in providing the theoretical base for applying AMP-jsa9 or its analogs to combat Gram-positive pathogenic bacteria in the food and feed industries.

Solution structure of LCI, a novel antimicrobial peptide from Bacillus subtilis.

Solution Structure of Carnobacteriocin B2 and Implications for Structure-Activity Relationships among Type IIa Bacteriocins from Lactic Acid Bacteria.

Crystallization and Preliminary Crystallographic Studies of Antibacterial Polypeptide LCI Expressed in Escherichia Coli.

The antibacterial activity and modes of LI-F type antimicrobial peptides against Bacillus cereus in vitro.

iTRAQ-based proteomic analysis of LI-F type peptides produced by Paenibacillus polymyxa JSa-9 mode of action against Bacillus cereus

The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties

A new structure-activity relationship of linear cationic α-helical antimicrobial peptides

Structural Basis of the Mechanisms of Action and Immunity of Lactococcin A, a Class IId Bacteriocin

Rational Design of Cationic Antimicrobial Peptides by the Tandem of Leucine-Rich Repeat.

Lysine-Tethered Stable Bicyclic Cationic Antimicrobial Peptide Combats Bacterial Infection in Vivo

Computational and Experimental Investigation of the Antimicrobial Peptide Cecropin XJ and Its Ligands As the Impact Factors of Antibacterial Activity

High-level expression of a hybrid antimicrobial peptide LfcinB-Cecropin in Escherichia coli and its activity

Isolation, Structure Elucidation, and Biosynthesis of a Cysteate-Containing Nonribosomal Peptide in Streptomyces Lincolnensis

Identification, Recombinant Expression, and Characterization of LGH2, a Novel Antimicrobial Peptide of Lactobacillus Casei HZ1

Structure and Function of a Potent Lipopolysaccharide-Binding Antimicrobial and Anti-Inflammatory Peptide.

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

The Terminal Structure Plays an Important Role in the Biological Activity of Cecropin CMIV

Structural Contributions to the Intracellular Targeting Strategies of Antimicrobial Peptides

High Cell Selectivity and Bactericidal Mechanism of Symmetric Peptides Centered on D-Pro–gly Pairs

Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity.

Novel Hybrid Peptide Cecropin A (1–8)-LL37 (17–30) with Potential Antibacterial Activity